Press Releases Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
733.5 ^USD	+1.19%		+0.99%	+25.83%

Apr. 25	Scholz pledges further support for the pharmaceutical industry	DP
Apr. 25	Scholz promises support for pharma sector in Germany as Merck invests	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eli Lilly and : Lilly Recommends Shareholders Reject “Mini-Tender” Offer by Tutanota LLC	Apr. 26	PU
ProQR Highlights Upcoming Presentations on Axiomer RNA Editing at ASGCT 27th Annual Meeting	Apr. 23	AQ
Eli Lilly and : Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals	Apr. 22	PU
6 Stocks Positioned to Soar as Investors Focus on MASH	Apr. 22	AQ
United Airlines, Eli Lilly rise; JB Hunt, Travelers fall, Wednesday, 4/17/2024	Apr. 17	AQ
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement	Apr. 16	PR
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib in Women with ER+/HER2- Breast Cancer	Apr. 16	AQ
Bayer - AskBio Names Mansuo Shannon Chief Scientific Officer	Apr. 10	AQ
Lilly - Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance on risk of heart failure hospitalization and death in adults following a heart attack	Apr. 08	AQ
Eli Lilly and : Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack	Apr. 06	PU
Eli Lilly and : Q1 Earnings 2024 Estimated Acquired IPR&D And Development Milestone Charges	Apr. 05	PU
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug	Mar. 08	AQ
Eli Lilly and Company - Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions about Obesity Care	Mar. 08	AQ
Eli Lilly and : Open Letter Regarding the Use of Mounjaro® (tirzepatide) and Zepbound® (tirzepatide)	Mar. 07	PU
Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care	Mar. 07	PR
Thinking about buying stock in SoundHound AI, Eli Lilly, Dell Technologies, NKGen Biotech, or Riot Platforms?	Mar. 06	PR
Lilly Announces Details of Presentations at 2024 American Association for Cancer Research Annual Meeting	Mar. 06	AQ
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023	Feb. 29	AQ
Lilly to Participate in Cowen's 44th Annual Health Care Conference	Feb. 20	PR
Eli Lilly and Company - Philip Johnson to Retire as Lilly Treasurer	Feb. 12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT